Pyruvate improves neutrophilic nitric oxide generation in peritoneal dialysis solutions

Artificial Organs

Volumn 29, Issue 12, 2005, Pages 976-980

  Wu, Yi Tai ^b   Wu, Zhao Long ^c   Jiang, Xiao Feng ^b   Li, Su ^b   Zhou, Fang Qiang ^a  

^a Fresenius Dialysis Centers   (United States)

^b TONGJI UNIVERSITY   (China)

^c ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Acidosis; Glucose; Hydride; Lactate; Nitric oxide; Peritoneal dialysis solutions; Pyruvate; Redox status; Sorbitol pathway; Zymosan

Indexed keywords

DIALYSIS; NITRIC OXIDE; PH;

ACIDIC PH; ACIDOSIS; HANKS BALANCED SALT SOLUTIONS; HIGH GLUCOSE; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS SOLUTION; PYRUVATES; REDOX STATUS; SORBITOL PATHWAY; ZYMOSAN;

GLUCOSE;

DIALYSIS FLUID; DIANEAL; GLUCOSE; LACTIC ACID; NITRIC OXIDE; PYRUVIC ACID; SORBITOL; ZYMOSAN; LACTIC ACID DERIVATIVE;

ACIDOSIS; ARTICLE; DIALYSIS; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; NEUTROPHIL; OPSONIZATION; OSMOLALITY; OXIDATION REDUCTION REACTION; PERITONEAL DIALYSIS; PERITONEUM CELL; PH; PRIORITY JOURNAL; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; METABOLISM; SPECTROPHOTOMETRY;

CELL SURVIVAL; CELLS, CULTURED; DIALYSIS SOLUTIONS; GLUCOSE; HUMANS; HYDROGEN-ION CONCENTRATION; LACTATES; NEUTROPHILS; NITRIC OXIDE; PERITONEAL DIALYSIS; PYRUVIC ACID; SPECTROPHOTOMETRY;

EID: 33644874194     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2005.00167.x     Document Type: Article

References (45)

1. Dal Sasso M Culici M Bianchi T Fonti E Braga PC. Inhibitory effects of metabolite I of erdosteine on the generation of nitric oxide and peroxynitrite chemiluminescence by human neutrophils. Pharmacology 2004 71 : 120 7.
2. Ing BL Gupta DK Nawab ZM Zhou F-Q Rahman MA Daugirdas JT. Suppression of neutrophil superoxide production by conventional peritoneal dialysis solution. Int J Artif Organs 1988 11 : 351 4.
3. Rodenas J Mitjavila MT Carbonell T. Nitric oxide inhibits superoxide production by inflammatory polymorphonuclear leukocytes. Am J Physiol 1998 274 : C827 30.
4. Yao V McCauley R Cooper D Platell C Hall JC. Zymosan induces nitric oxide production by peritoneal mesothelial cells. ANZ J Surg 2004 74 : 266 9.
5. Davenport A Fernando RL Varghese Z. Intraperitoneal nitric oxide production in patients treated by continuous ambulartory peritoneal dialysis. Blood Purif 2004 22 : 216 23.
6. Ing TS Wong FKM Yu AW Zhou FQ Gandhi VC Patel HM. Effect of an acidic, pyruvate-based or an acidic, lactate-based peritoneal dialysis solution (PDS) on neutrophilic oxygen consumption. Perit Dial Int 1995 15 ( Suppl. S33.
7. Mahiout A Matata BM Brunkhorst R Kaur D Williams JD Topley N. The effect of glucose, lactate, and pyruvate on cell respiration in peritoneal macrophages. Perit Dial Int 1997 17 ( Suppl. 1 S34.
8. Wu YT Wu ZL Jiang XF Li S Zhou FQ. Pyruvate preserves neutrophilic superoxide production in acidic, high glucose-enriched peritoneal dialysis solutions. Artif Organs 2003 27 : 276 81.
9. Fossati G Moulding DA Spiller DG Moots RJ White MRH Edwards SW. The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis. J Immunol 2003 170 : 1964 72.
10. Maianski NA Maianski AN Kuijpers TW Roos D. Apoptosis of neutrophils. Acta Haematol 2004 111 : 56 66.
11. Welten AGA Zareie M van den Born J, et al. In vitro and in vivo models for peritonitis demonstrate unchanged neutrophil migration after exposure to dialysis fluids. Nephrol Dial Transplant 2004 19 : 831 9.
12. Yu AW Zhou XJ Zhou FQ, et al. Neutrophilic intracellular acidosis induced by conventional, lactate-containing peritoneal dialysis solutions. Int J Artif Organs 1992 15 : 661 5.
13. Douvdevani A Rapoport J Konforty A Yulzari R Moran A Chaimovitz C. Intracellular acidification mediates the inhibitory effect of peritoneal dialysate on peritoneal macrophages. J Am Soc Nephrol 1995 6 : 207 13.
14. Zhou FQ Zhou JX Yu AW Song RH. Neutrophilic transient acidification and superoxide production in peritoneal dialysate. Chin Med Sci J 1999 14 : 215 9.
15. Ing TS Zhou XJ Yu AW Zhou FQ Vaziri ND. Effects of pyruvate-based or lactate-based peritoneal dialysis solutions on neutrophil intracellular pH. Int J Artif Organs 1997 20 : 255 60.
16. Ing TS Yu AW Guddeti SR Sekhri R Yang ML Zhou FQ. An acidic, pyruvate-based peritoneal dialysis solution (PDS) lowers the pH of a residual peritoneal dialysate fluid to a less extent than does an equally acidic, lactate-based counterpart. ASAIO J 1995 41 : 101A.
17. Kaur D Williams JD Wilkinson T Mahiout A Hallelt H Topley N. The improved function of neutrophils (PMN) in pyruvate-buffered peritoneal dialysis fluids (Pyr-PDF) is related to its pKa' and its reduced effect on intracellular acidification. Perit Dial Int 1997 17 ( Suppl. 1 S33.
18. Griffin JL White LT Lewandowski ED. Substrate-dependent proton load and recovery of stunned heart during pyruvate dehydrogenase stimulation. Am J Physiol 2000 279 : H361 7.
19. Zhou FQ. Pyruvate improvement of cellular energetics, not simply generating ATP during anoxia. Transplantation 2002 73 : 1851.
20. Zhou FQ. Pyruvate in the correction of intracellular acidosis: a metabolic basis as a novel superior buffer. Am J Nephrol 2005 25 : 55 63.
21. +-ATPase. J Biol Chem 2004 279 : 8732 9.
22. +-ATPase interacts with phosphofructokinase-1 in humans. J Biol Chem 2003 278 : 20013 8.
23. ter Wee PM Brulez HFH Snijders SV Donker AJM Verbrugh HA. Improvement of leukocyte viability and function in vitro with bicarbonate-pyruvate buffered peritoneal dialysis (PD) fluids. J Am Soc Nephrol 1998 9 : 273A.
24. Zhou FQ. Advantages of pyruvate over lactate in peritoneal dialysis solutions. Acta Pharmacol Sin 2001 22 : 385 92.
25. Wang S Li X. Effects of pyruvate buffered peritoneal dialysis solution on peritoneal macrophages function, electrolytes metabolism, acid-base balance and peritoneal mesothelium in uremic rats. Chin J Nephrol 2001 17 : 365 8.
26. Sharma P Walsh KT Kerr-Knott KA Karaian JE Mongan PD. Pyruvate modulates hepatic mitochondrial function and reduces apoptosis indicators during hemorrhagic shock in rats. Anesthesiology 2005 103 : 65 73.
27. Mongan PD Karaian J Van Der Schuur BM Via DK Sharma P. Pyruvate prevents poly-ADP ribose polymerase (PARP) activation, oxidative damage, and pyruvate dehydrogenase deactivation during hemorrhagic shock in swine. J Surg Res 2003 112 : 180 8.
28. Prabhakar SS. Inhibition of mesangial iNOS by reduced extracellular pH is associated with uncoupling of NADPH oxidation. Kidney Int 2002 61 : 2015 24.
29. Rettich A Suschek C Grabensee B Plum J. Effects of different dialysis fluids on nitric oxide production of vascular endothelial cells. Perit Dial Int 2001 21 ( Suppl. 1 S18.
30. Tebbs SE Gonzalez AM Wilson RM. The role of aldose reductase inhibition in diabetic neutrophil phagocytosis and killing. Clin Exp Immunol 1991 84 : 482 7.
31. Wong TYH Philips AO Witowski J Topley N. Glucose-mediated induction of TGF-B1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int 2003 63 : 1404 16.
32. van Westrhenen R Aten J Aberra M Dragt CAM Deira G Krediet RT. Inhibition of the polyol pathway during chronic peritoneal exposure. Perit Dial Int 2004 24 ( Suppl. 2 S69.
33. Krediet RT van Westrhenen R Zweers MM Struijk DG. Clinical advantages of new peritoneal dialysis solutions. Nephrol Dial Transplant 2002 17 ( Suppl. 3 16 8.
34. Kaur D Williams JD Phillips AO Topley N. Improved cell function in pyruvate-buffered peritoneal dialysis fluids (Pyr-PDF) is related to specific antagonism of the polyol pathway. J Am Soc Nephrol 1997 18 : 266A.
35. Stevens MJ Dananberg J Feldman EL, et al. The linked roles of nitric oxide, aldose reductase and, (Na+, K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest 1994 94 : 853 89.
36. Ramasamy R Oates PJ Schaefer S. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury. Diabetes 1997 46 : 292 300.
37. Trueblood N Ramasamy R. Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts. Am J Physiol 1998 275 : H75 83.
38. Okuda Y Kawashima K Suzuki S, et al. Restoration of nitric oxide production by aldose reductase inhibitor in human endothelial cells cultured in high-glucose medium. Life Sci 1997 60 : 53 6.
39. Hwang YC Sato S Tsai JY, et al. Aldose reductase activation is a key component of myocardial response to ischemia. FASEB J 2002 16 : 243 5.
40. Varma SD Ramachandran S Devamanoharan PS Morris SM Ali AH. Prevention of oxidative damage to rat lens by pyruvate in vitro: possible attenuation in vivo. Curr Eye Res 1995 14 : 643 9.
41. Rapoport I Elsner R Muller M Dumdey R Rapoport S. NADPH production in the oxidative pentose phosphate pathway as a source of reducing equivalents in glycolysis in human red cells in vitro. Acta Biol Med Ger 1979 38 : 901 8.
42. Fink MP. Ringer's ethyl pyruvate solution: a novel resuscitation fluid. Minerva Anestesiol 2001 67 : 190 2.
43. Zima AV Kockskamper J Mejia-Alvarez R Blatter LA. Pyruvate modulates cardiac sarcoplasmic reticulum Ca2+ release in rats via mitochondria-dependent and -independent mechanisms. J Physiol 2003 550 : 765 83.
44. Polytarchou C Papadimitriou E. Antioxidants inhibits angiogenesis in vivo through down-regulation of nitric oxide synthetase expression and activity. Free Radic Res 2004 38 : 501 8.
45. Lee MS Moon EJ Lee SW Kim MS Kim KW Kim YJ. Angiogenic activity of pyruvic acid in in vivo and in vitro angiogenesis models. Cancer Res 2001 61 : 3290 3.